Nov 16th, 2016
November 16, 2016: In this issue Academics/Administrative Fall 2016 Drop/Withdrawal Deadline: Nov 21 *Monday* Feeling Stressed, Anxious or Discouraged? *New* GATORRATER Faculty Evaluations Open Tuesday *New* Register for Undergraduate Research […]
Nov 2nd, 2016
November 2, 2016: In this issue Academics/Administrative Spring 2017 Schedule of Courses Available HHP Academic Advising Hours/Availability HHP Teacher/Adviser of the Year Nominations FAFSA Deadline: December 15th Events Memorial Service […]
Oct 26th, 2016
October 26, 2016: In this issue Academics/Administrative Spring 2017 Schedule of Courses Available HHP Academic Advising Hours/Availability HHP Teacher/Adviser of the Year Nominations FAFSA Deadline: December 15th Events UF Graduate […]
Oct 19th, 2016
October 19, 2016: In this issue Academics/Administrative Spring 2017 Schedule of Courses Available HHP Academic Advising Hours/Availability HHP Teacher/Adviser of the Year Nominations FAFSA Deadline: December 15th Events Gator Career […]
Oct 12th, 2016
October 12, 2016: In this issue Academics/Administrative Spring 2017 Schedule of Courses Available HHP Academic Advising Hours/Availability HHP Teacher/Adviser of the Year Nominations STRIVE at GatorWell: Sexual Consent Campaign FAFSA […]
Oct 5th, 2016
October 5, 2016: In this issue Academics/Administrative Spring 2017 Schedule of Courses Coming Soon *Friday* HHP Academic Advising Hours/Availability Athletic Training Admissions Forum: Oct 10 *Monday* HHP Teacher/Adviser of the […]
Sep 28th, 2016
September 28, 2016: In this issue Academics Spring 2017 Schedule of Courses Coming Soon *New* HHP Academic Advising Hours/Availability Athletic Training Admissions Forum: Oct 10 HHP Teacher/Adviser of the Year […]
Sep 21st, 2016
September 21, 2016: In this issue Academics HHP Academic Advising Hours/Availability Athletic Training Admissions Forum: Oct 10 HHP Teacher/Adviser of the Year Nominations Events Study Abroad Fair: Sept 21 *Today* […]
November 29, 2016
The University of Florida has received a grant of nearly $10 million from the Centers for Disease Control and Prevention through the National Institute of Occupational Safety and Health, or NIOSH, for a five-year project to explore the occupational safety and health of people working in agriculture, fishing and forestry in Florida, Georgia, Alabama, Mississippi and North and South Carolina. The goal of the new center is to conduct research and educational activities designed to promote occupational health and safety among Florida’s 47,000 farm operators and their families, as well as their employees and contractors. “Much of the data about Florida’s agricultural safety and health is over a decade old,” said J. Glenn Morris, M.D., M.P.H., director of UF’s Emerging Pathogens Institute and a professor in the UF College of Public Health and Health Professions and the UF College of Medicine. “We need to add to the body of knowledge about farming, fishing and forestry workers in the region, so we proposed establishing a center that will facilitate collaboration with researchers throughout the Southeast.” Morris is the director of the center, called the Southeastern and Coastal Center for Agricultural Safety and Health, or SEC-CAgSH. It will be the 11th U.S. Agricultural Safety and Health center sponsored by NIOSH. While the University of Florida is the hosting institution, researchers from the University of South Florida, Florida State University, Emory University and Florida A&M have all agreed to work together on projects aiming to better understand the region’s occupational safety and health needs. NIOSH has awarded the grant to UF’s College of Public Health and Health Professions. Researchers from several UF colleges will participate. “This center provides an exciting opportunity for UF faculty to use their scientific expertise to address vital public health questions that will enhance the safety and well-being of people whose work is critical to our agricultural and seafood industries,” said Michael G. Perri, Ph.D., dean of the College of Public Health and Health Professions. Faculty members from the UF Institute of Food and Agricultural Sciences, or IFAS, are also involved in the project. “Protecting the health of those who provide the labor for the $155 billion-a-year agriculture and natural resources industry has long been a focus area of IFAS research and Extension,” said Jack Payne, Ph.D., senior vice president of agriculture and natural resources. “UF is particularly qualified to address such complexities because of the comprehensive expertise it has. “The partnership between IFAS research and Extension, PHHP and EPI will create a powerful interdisciplinary focus on agricultural safety and health that will provide the industry with the tools and training to maintain a healthy workforce,’’ Payne said. The center will provide an opportunity to expand UF’s current training and outreach programs throughout the state and eventually the Southeast region, while developing new educational materials and methods of dissemination for diverse audiences. Several projects are already underway. Andrew Kane, Ph.D., an associate professor in the UF College of Public Health and Health Professions’ department of environmental and global health, serves as the center’s associate director and lead investigator of the research project focused on Gulf seafood worker safety. Seafood industry workers are exposed to some of the greatest occupational risks nationally, according to Kane. While there are numerous anecdotal reports of injuries, very little data exists on worker health and safety in this largely self-employed and self-insured population. Kane’s team seeks to extend current knowledge about everyday hazards and risks in northeastern Gulf fisheries through surveys, direct observations, community engagement and expanded academic and community partnerships. The team will then develop, implement and assess community-based training activities aimed at reducing injuries. Gregory Glass, Ph.D., and Joseph Grzywacz, Ph.D., will also lead projects at the center. Glass, a professor of geography and a member of the Emerging Pathogens Institute, will use remote sensing technology to estimate the levels of pesticide and herbicide usage in Florida’s croplands. Grzywacz, a professor in Florida State University’s College of Human Sciences and the chair of the department of family and child sciences, will develop and test whether safety and education materials produce changes in safety behaviors among Latino farmworkers. Tracy Irani, Ph.D., a professor in UF/IFAS and the chair of the department of family, youth, and community sciences, will oversee the center’s outreach and community engagement efforts. “Our role in the center will entail working with communities to identify the particular needs that are specific to agricultural production in Florida and the Southeast,” Irani said. “We also plan to develop new materials and utilize new media to reach our target populations in new ways.” Agriculture, fishing and forestry comprise a multibillion-dollar industry in the state of Florida. Florida is the second largest producer of fresh fruit and vegetable crops in the nation. Oranges alone generate more than $1.3 billion of annual sales, ranking as Florida’s second most important single commodity after greenhouse/nursery products, according to the USDA. The farm value of fresh market tomatoes, the state’s third most important commodity, averages about $500 million annually. The production and harvesting of these and other specialty crops grown in Florida depends on agricultural workers who produce and harvest citrus, fresh market vegetables, strawberries, blueberries and melons, as well as ornamental plants for the landscape and environmental horticulture sector. According to a UF/IFAS study, one acre of tomatoes is estimated to require more than 200 labor hours to plant, grow, harvest and pack for the fresh market. One acre of citrus harvesting requires between 50 and 60 hours of manual labor.
November 18, 2016
University of Florida researchers have developed a template showing the brain’s superhighways and how they are impacted by a stroke. The brain images required to create the template were processed on HiPerGator, UF's supercomputer. “We’re interested in the structure of the brain after a stroke,” said Stephen Coombes, assistant professor of applied physiology and kinesiology, who developed the template with post-doctoral research associate Derek Archer. “Collecting and analyzing images of brains from people that haven’t experienced a stroke helps us track the different motor pathways in the brain; sort of a ‘Google Maps’ for the brain’s corticospinal tract.” The benefits of mapping the corticospinal tract — it’s a superhighway for movement — can have a significant impact to the care and recovery of stroke patients. “Knowing which part of the tract is damaged may be extremely helpful in predicting recovery after stroke,” Coombes said. “Physical therapists can also use this information to prescribe more individualized rehabilitation exercises.” Utilizing 3,000 HiPerGator cores, the team's imaging needs were completed in three months. Without HiPerGator’s processing power, analyzing the data on a single computer would have taken 42 years of processing time. For more information about Coombes’s and Archer’s work on the corticospinal tract template and its applied use capabilities, visit the Laboratory for Rehabilitation Neuroscience web page.
November 16, 2016
A quick, precise genetic test can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients, a group led by University of Florida Health researchers has found. The test identifies a genetic deficiency that affects the body’s ability to activate clopidogrel, a common anti-clotting drug given after a coronary artery stent is inserted. During a recent study from the National Institutes of Health’s Implementing Genomics in Practice (IGNITE) Network, researchers at UF Health and other sites throughout the country analyzed medical outcomes in 1,815 patients who had genetic testing at the time of their cardiac procedure. The genetic testing allows physicians to pinpoint the best anti-clotting medication for each patient. The study reported significant results: About 60 percent of patients with the genetic deficiency were given a different, more effective medication. Using the genetic data to guide changes in therapy reduced the percentage of deaths, heart attacks or strokes by nearly half compared with those who continued taking clopidogrel, the researchers found. Among those who had the genetic deficiency and continued taking clopidogrel, 8 percent of patients experienced one of those complications. Their findings are being presented today (Nov. 15) at the American Heart Association’s Scientific Sessions in New Orleans. The study examined the effect of genotype-guided treatment on cardiovascular outcomes after a heart procedure known as percutaneous coronary intervention, or PCI, in which a metallic stent is inserted into a heart artery to treat a blockage. More broadly, one UF Health researcher said it shows the power and the promise of personalized medicine, which tailors medical decisions based on a patient’s genetic information and other unique characteristics. “We saw significantly fewer adverse events among patients who were switched to an alternative drug,” said Larisa Cavallari, Pharm.D., director of the Center for Pharmacogenomics at the UF College of Pharmacy and associate director of the UF Health Personalized Medicine Program, which was created in 2011 within the UF Clinical and Translational Science Institute. About 30 percent of all patients have a genetic deficiency that impairs their ability to activate the drug, which can lead to decreased clopidogrel effectiveness and increased risk for adverse cardiovascular events such as strokes, heart attacks and death. Having timely access to a patient’s genetic information can be particularly helpful as physicians work to prescribe the most appropriate medicine. “This is an important breakthrough in personalized medicine because it shows how a genetic marker can be used to modify treatments and improve patient outcomes,” said Dominick J. Angiolillo, M.D., Ph.D., a cardiologist, professor of medicine and director of cardiovascular research at UF Health Jacksonville. In addition to pinpointing the best drug for PCI patients, the genetic testing is efficient. On average during the study, a patient’s genetic information was available in about one day and an alternative medication was provided within a similar time. “There was prompt genotyping and the patients were quickly given the drug we thought would work best for them,” Cavallari said. Yet decoding a patient’s genetic tendencies isn’t just about rapid treatment: Many patients take an anti-clotting drug for a year or longer. Patients who had the genetic deficiency and received an alternative medication were less likely to have a major adverse cardiovascular event compared with those who received clopidogrel during the follow-up period of up to a year, researchers found. The findings are the first from a large group of U.S. patients to show that the risk of cardiovascular problems is reduced when PCI patients with a genetic deficiency get an alternative medication, said Deepak Voora, M.D., a cardiologist and member of the Center for Applied Genomics & Precision Medicine at Duke University and a co-author of the current study. “This should give patients who carry the genetic variant and their providers confidence to use more effective, alternative medications,” Voora said. The genetic test that identifies a patient’s response to clopidogrel is already being used at UF Health hospitals in Gainesville and Jacksonville and other sites that contributed to these results. Patient samples for the UF Health sites are analyzed by UF Health pathology labs, which helps to expedite results. In most cases, test results at UF Health Jacksonville are available within an hour. That helps physicians decide in a timely manner which drug to prescribe, Angiolillo said. The findings being presented today are encouraging, said R. David Anderson, a UF Health interventional cardiologist and professor in the department of medicine division of cardiovascular medicine who assisted with Cavallari’s study. The results of pending clinical trials may help to determine whether or not the genotyping for clopidogrel response becomes more widely used in cardiac care, Anderson said. However, clinical trial data may not be available for several years. In the meantime, Cavallari said, data such as these from patients genotyped as part of clinical care support broader implementation. The current research was organized through a collaborative genomic medicine network funded by the NIH and known as Implementing Genomics in Practice, or IGNITE. Other institutions that participated in the clopidogrel research were the University of North Carolina, the University of Maryland-Baltimore, the University of Pittsburgh, the University of Alabama-Birmingham, Vanderbilt University Medical Center, the University of Illinois-Chicago, Indiana University-Indianapolis, Sanford Health, Duke University and the University of Pennsylvania.